Get started
HIMS & HERS HEALTH INCHIMS & HERS HEALTH INCHIMS & HERS HEALTH INC

HIMS & HERS HEALTH INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

82W chart


Full chart

Key facts today


Hims & Hers Health's Q1 earnings beat estimates, but its long-term sales outlook fell short. For Q2, it expects revenue of $530-$550 million, below the $564.6 million forecast. Stock rose 18%.
Analyze the impactAnalyze the impact

82W upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.28 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
60.34
Basic EPS (TTM)
0.70 EUR
Net income (FY)
‪121.75 M‬ EUR
Revenue (FY)
‪1.43 B‬ EUR
Shares float
‪183.36 M‬
Beta (1Y)
3.23

Employees


Employees (FY)
‪1.64 K‬
Change (1Y)
+591 +56.50%
Revenue / Employee (1Y)
‪871.28 K‬ EUR
Net income / Employee (1Y)
‪74.37 K‬ EUR

About Hims & Hers Health, Inc.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Andrew Dudum
Website
forhims.com
Headquarters
San Francisco
Founded
2017
FIGI
BBG00W6VZLR0
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

82W news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 82W.

Frequently Asked Questions


The current price of 82W is 46.49 EUR — it has increased by 18.18% in the past 24 hours. Watch HIMS & HERS HEALTH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HIMS & HERS HEALTH INC stocks are traded under the ticker 82W.
82W stock has risen by 70.88% compared to the previous week, the month change is a 74.88% rise, over the last year HIMS & HERS HEALTH INC has showed a 272.81% increase.
We've gathered analysts' opinions on HIMS & HERS HEALTH INC future price: according to them, 82W price has a max estimate of 74.75 EUR and a min estimate of 21.99 EUR. Watch 82W chart and read a more detailed HIMS & HERS HEALTH INC stock forecast: see what analysts think of HIMS & HERS HEALTH INC and suggest that you do with its stocks.
82W reached its all-time high on Feb 19, 2025 with the price of 70.20 EUR, and its all-time low was 2.62 EUR and was reached on May 12, 2022. View more price dynamics on 82W chart.
See other stocks reaching their highest and lowest prices.
82W stock is 12.78% volatile and has beta coefficient of 3.23. Track HIMS & HERS HEALTH INC stock price on the chart and check out the list of the most volatile stocks — is HIMS & HERS HEALTH INC there?
Today HIMS & HERS HEALTH INC has the market capitalization of ‪9.73 B‬, it has increased by 30.46% over the last week.
Yes, you can track HIMS & HERS HEALTH INC financials in yearly and quarterly reports right on TradingView.
HIMS & HERS HEALTH INC is going to release the next earnings report on Aug 11, 2025. Keep track of upcoming events with our Earnings Calendar.
82W earnings for the last quarter are 0.18 EUR per share, whereas the estimation was 0.11 EUR resulting in a 65.41% surprise. The estimated earnings for the next quarter are 0.12 EUR per share. See more details about HIMS & HERS HEALTH INC earnings.
HIMS & HERS HEALTH INC revenue for the last quarter amounts to ‪541.67 M‬ EUR, despite the estimated figure of ‪497.84 M‬ EUR. In the next quarter, revenue is expected to reach ‪485.68 M‬ EUR.
82W net income for the last quarter is ‪45.74 M‬ EUR, while the quarter before that showed ‪25.14 M‬ EUR of net income which accounts for 81.95% change. Track more HIMS & HERS HEALTH INC financial stats to get the full picture.
No, 82W doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has ‪1.64 K‬ employees. See our rating of the largest employees — is HIMS & HERS HEALTH INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIMS & HERS HEALTH INC EBITDA is ‪127.50 M‬ EUR, and current EBITDA margin is 5.76%. See more stats in HIMS & HERS HEALTH INC financial statements.
Like other stocks, 82W shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIMS & HERS HEALTH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIMS & HERS HEALTH INC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIMS & HERS HEALTH INC stock shows the strong buy signal. See more of HIMS & HERS HEALTH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.